Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionBenjamin F. Edwards & Company, Inc.
Latest Disclosed Ownership5,892 shares
Latest Disclosed Value $ 2,761
Benjamin F. Edwards & Company, Inc. reports 18.79% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On August 12, 2024 - Benjamin F. Edwards & Company, Inc. filed a 13F-HR form disclosing ownership of 5,892 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $2,761,698 USD as of June 30, 2024. The entity filed a previous 13F-HR on April 29, 2024 disclosing 4,960 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 18.79% during the quarter. The current value of the position is $2,523,779 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2024-08-12 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,892 932 18.79 3 0.00 0.0485
2024-04-29 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,960 1,288 35.08 2 100.00 0.0376
2024-02-06 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,672 859 30.54 1 0.0300
2023-11-13 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,813 126 4.69 1 0.0376
2023-08-15 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,687 99 3.83 1 0.0360
2023-04-27 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,588 -96 -3.58 1 0.0341
2023-02-07 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,684 0 0.00 1 -100.00 0.0348
2022-10-28 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,684 -2 -0.07 777 2.64 0.0390
2022-08-12 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,686 -598 -18.21 757 -11.67 0.0366
2022-05-04 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,284 0 0.00 857 18.86 0.0383
2022-02-07 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,284 600 22.35 721 48.05 0.0321
2021-11-02 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,684 0 0.00 487 -9.98 0.0245
2021-08-11 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,684 -802 -23.01 541 -27.77 0.0276
2021-05-14 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,486 86 2.53 749 -6.84 0.0403
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,400 119 3.63 804 -9.97 0.0478
2020-11-13 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,281 -855 -20.67 893 -25.65 0.0599
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,136 1,157 38.84 1,201 69.39 0.0872
2020-05-07 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,979 183 6.55 709 15.85 0.0606
2020-02-06 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,796 0 0.00 612 29.11 0.0430
2019-11-05 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,796 2,582 1,206.54 474 1,115.38 0.0371
2019-08-08 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 214 6 2.88 39 2.63 0.0033
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 208 0 0.00 38 11.76 0.0034
2019-01-31 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 208 42 25.30 34 6.25 0.0035
2018-10-29 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 166 56 50.91 32 68.42 0.0030
2018-07-19 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 110 10 10.00 19 18.75 0.0019
2018-04-17 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 100 0 0.00 16 6.67 0.0016
2018-01-17 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 100 0 0.00 15 0.00 0.0016
2017-10-24 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 100 -14 -12.28 15 0.00 0.0018
2017-07-26 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 114 0 0.00 15 25.00 0.0020
2017-05-04 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 114 0 0.00 12 50.00 0.0018
2017-01-18 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 114 0 0.00 8 -20.00 0.0013
2016-10-24 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 114 14 14.00 10 11.11 0.0018
2016-07-08 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 100 0 0.00 9 12.50 0.0018
2016-04-13 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 100 0 0.00 8 -38.46 0.0017
2016-01-12 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 100 0 0.00 13 30.00
2015-10-16 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 100 -438 -81.41 10 -84.85 0.0022
2015-07-10 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 538 259 92.83 66 100.00 0.0132
2015-04-14 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 279 179 179.00 33 175.00 0.0069
2015-02-06 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 100 0 0.00 12 9.09 0.0028
2014-11-06 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 100 0 0.00 11 22.22 0.0027
2014-07-21 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 100 0 0.00 9 28.57 0.0023
2014-04-14 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 100 0 0.00 7 0.00 0.0019
2014-01-15 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 100 -31 -23.66 7 -30.00 0.0024
2013-11-07 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 131 0 0.00 10 0.00 0.0037
2013-07-30 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 131 131 10 0.0040
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.